{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:36:48Z","timestamp":1791689808292,"version":"4.3.4"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21AI167793"],"award-info":[{"award-number":["1R21AI167793"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA273002"],"award-info":[{"award-number":["R01CA273002"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA282254"],"award-info":[{"award-number":["R01CA282254"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jtauto.2025.100313","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:12:57Z","timestamp":1756480377000},"page":"100313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Redefining multiple sclerosis therapy through microbial immunomodulation and epigenetic control"],"prefix":"10.1016","volume":"11","author":[{"given":"Shan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina James","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunilgowda Sunnagatta","family":"Nagaraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duminduni Hewa","family":"Angappulige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy Fang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krish","family":"Suman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Borja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"de Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9734-6176","authenticated-orcid":false,"given":"Jianxun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.jtauto.2025.100313_bib1","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler. J."},{"issue":"2\u20133","key":"10.1016\/j.jtauto.2025.100313_bib2","article-title":"The epidemiology of multiple sclerosis in Queensland, Australia","volume":"80","author":"Hammond","year":"1987","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100313_bib3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/17843286.2016.1147675","article-title":"Rare onset symptoms in multiple sclerosis","volume":"71","author":"Evlice","year":"2016","journal-title":"Acta Clin. Belg."},{"key":"10.1016\/j.jtauto.2025.100313_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s100720100044","article-title":"The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes","volume":"22","author":"Trojano","year":"2001","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.jtauto.2025.100313_bib5","doi-asserted-by":"crossref","DOI":"10.4103\/0028-3886.28108","article-title":"Differential patterns of memory performance in relapsing, remitting and secondary progressive multiple sclerosis","volume":"54","author":"Drake","year":"2006","journal-title":"Neurol. India"},{"issue":"24","key":"10.1016\/j.jtauto.2025.100313_bib6","article-title":"The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis","volume":"90","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jtauto.2025.100313_bib7","article-title":"Neuropathology and applied neurobiology","volume":"44","author":"Carassiti","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"10","key":"10.1016\/j.jtauto.2025.100313_bib8","article-title":"Class II HLA interactions modulate genetic risk for multiple sclerosis","volume":"47","year":"2015","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib9","article-title":"A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis","volume":"10","year":"2019","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.jtauto.2025.100313_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.jtauto.2025.100313_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.jtauto.2025.100313_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/ana.1123","article-title":"Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions","volume":"50","author":"Peterson","year":"2001","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100313_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2567.2008.02837.x","article-title":"T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis","volume":"125","author":"Hedegaard","year":"2008","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.jtauto.2025.100313_bib14","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T cell activation State characterized by the production of Interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100313_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/nm1551","article-title":"A brief history of TH17, the first major revision in the TH1\/TH2 hypothesis of T cell\u2013mediated tissue damage","volume":"13","author":"Steinman","year":"2007","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100313_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2010.05.005","article-title":"Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis","volume":"59","author":"Jadidi-Niaragh","year":"2010","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.jtauto.2025.100313_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41564-024-01699-6","article-title":"Multiple sclerosis patient-derived spontaneous B cells have distinct EBV and host gene expression profiles in active disease","volume":"9","author":"Soldan","year":"2024","journal-title":"Nat. Microbiol."},{"issue":"6","key":"10.1016\/j.jtauto.2025.100313_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/ana.25365","article-title":"Meningeal inflammation and cortical demyelination in acute multiple sclerosis","volume":"84","author":"Bevan","year":"2018","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.jtauto.2025.100313_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-019-0035-2","article-title":"Progressive multiple sclerosis: from pathophysiology to therapeutic strategies","volume":"18","author":"Faissner","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.jtauto.2025.100313_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awn096","article-title":"Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis","volume":"131","author":"Kuhlmann","year":"2008","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jtauto.2025.100313_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/ene.12715","article-title":"Cognitive impairment in a population\u2010based study of patients with multiple sclerosis: differences between late relapsing\u2212remitting, secondary progressive and primary progressive multiple sclerosis","volume":"23","author":"Planche","year":"2016","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.jtauto.2025.100313_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awq076","article-title":"Evidence for a two-stage disability progression in multiple sclerosis","volume":"133","author":"Leray","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jtauto.2025.100313_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-443-23841-3.00013-3","article-title":"Immunosuppressive and immunomodulatory therapies","author":"Patel","year":"2025","journal-title":"Target. Therap. Central Nerv. Sys."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s11011-021-00800-w","article-title":"Neurodegenerative disorders of alzheimer, parkinsonism, amyotrophic lateral sclerosis and multiple sclerosis: an early diagnostic approach for precision treatment","volume":"37","author":"Pathak","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"6","key":"10.1016\/j.jtauto.2025.100313_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.mibio.2003.09.010","article-title":"2-dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease","volume":"5","author":"Agdeppa","year":"2003","journal-title":"Mol. Imag. Biol."},{"issue":"12","key":"10.1016\/j.jtauto.2025.100313_bib26","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1525528113","article-title":"New tools for studying microglia in the mouse and human CNS","volume":"113","author":"Bennett","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100313_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2018.01.011","article-title":"High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease","volume":"48","author":"Mrdjen","year":"2018","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.jtauto.2025.100313_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2012.03.014","article-title":"JAK and STAT signaling molecules in immunoregulation and immune-mediated disease","volume":"36","author":"O'Shea","year":"2012","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.jtauto.2025.100313_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/eji.201646716","article-title":"TGF-\u03b2 regulation of T cells in multiple sclerosis","volume":"47","author":"Lee","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jtauto.2025.100313_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00378","article-title":"Frontiers | crosstalk between Wnt\/\u03b2-Catenin and NF-\u03baB signaling pathway during inflammation","volume":"7","author":"Ma","year":"2016","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/nrc3860","article-title":"PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting","volume":"15","author":"Thorpe","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jtauto.2025.100313_bib32","series-title":"Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases","author":"Clark","year":"2014"},{"key":"10.1016\/j.jtauto.2025.100313_bib33","first-page":"10","article-title":"JAK\/STAT pathways in cytokine signaling and myeloproliferative disorders","author":"Jatiani","year":"2010","journal-title":"Genes Cancer"},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2017.12.008","article-title":"Structural activation of pro-inflammatory human cytokine IL-23 by cognate IL-23 receptor enables recruitment of the shared receptor IL-12R\u03b21","volume":"48","author":"Bloch","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jtauto.2025.100313_bib35","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/ijms24010864","article-title":"The role of the JAK\/STAT signaling pathway in the pathogenesis of Alzheimer's disease: new potential treatment target","volume":"24","author":"Rusek","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.jtauto.2025.100313_bib36","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1913997117","article-title":"STAT3 signaling in myeloid cells promotes pathogenic myelin-specific T cell differentiation and autoimmune demyelination","volume":"117","author":"Lu","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jtauto.2025.100313_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2014.03.009","article-title":"Th17 cells in central nervous system autoimmunity","volume":"262","author":"Sie","year":"2014","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib38","article-title":"Th17 cells pathways in multiple sclerosis and neuromyelitis Optica spectrum disorders: pathophysiological and therapeutic implications","author":"Passos","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jtauto.2025.100313_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2020.10.013","article-title":"Microbiota metabolites modulate the T helper 17 to regulatory T cell (Th17\/Treg) imbalance promoting resilience to stress-induced anxiety- and depressive-like behaviors","volume":"91","author":"Westfall","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"7738","key":"10.1016\/j.jtauto.2025.100313_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-018-0824-5","article-title":"Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery","volume":"565","author":"Ito","year":"2019","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.jtauto.2025.100313_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/nn.3469","article-title":"M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination","volume":"16","author":"Miron","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.jtauto.2025.100313_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.it.2004.03.008","article-title":"The two NF-\u03baB activation pathways and their role in innate and adaptive immunity","volume":"25","author":"Bonizzi","year":"2004","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.jtauto.2025.100313_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/sj.cdd.4401837","article-title":"Roles for NF-\u03baB in nerve cell survival, plasticity, and disease","volume":"13","author":"Mattson","year":"2006","journal-title":"Cell Death Differ."},{"issue":"7","key":"10.1016\/j.jtauto.2025.100313_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41583-023-00709-6","article-title":"Roles and regulation of microglia activity in multiple sclerosis: insights from animal models","volume":"24","author":"Dist\u00e9fano-Gagn\u00e9","year":"2023","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.jtauto.2025.100313_bib45","article-title":"Curcumin and plumbagin synergistically target the PI3K\/Akt\/mTOR pathway: a prospective role in cancer treatment - PubMed","volume":"24","author":"I","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jtauto.2025.100313_bib46","doi-asserted-by":"crossref","DOI":"10.1177\/1758834014530023","article-title":"The PI3K\/AKT\/mTOR pathway in breast cancer: targets, trials and biomarkers","volume":"6","author":"Paplomata","year":"2014","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.jtauto.2025.100313_bib47","article-title":"PLC and PI3K\/Akt\/mTOR signalling in disease and cancer","volume":"vol. 57","author":"Follo","year":"2015"},{"issue":"9","key":"10.1016\/j.jtauto.2025.100313_bib48","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.23862","article-title":"Preclinical evaluation of the PI3K\/Akt\/mTOR pathway in animal models of multiple sclerosis","volume":"9","author":"Mammana","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtauto.2025.100313_bib49","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.3390\/ijms23158077","article-title":"The mTOR signaling pathway in multiple sclerosis; from animal models to human data","volume":"23","author":"Vakrakou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2025.100313_bib50","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3390\/pharmaceutics15031006","article-title":"The exosome-mediated PI3K\/Akt\/mTOR signaling pathway in neurological diseases","volume":"15","author":"Iranpanah","year":"2023","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.jtauto.2025.100313_bib51","doi-asserted-by":"crossref","DOI":"10.1007\/s10753-024-02099-y","article-title":"Methylprednisolone modulates the Tfr\/Tfh ratio in EAE-Induced neuroinflammation through the PI3K\/AKT\/FoxO1 and PI3K\/AKT\/mTOR signalling pathways","volume":"48","author":"Wu","year":"2024","journal-title":"Inflammation"},{"issue":"4","key":"10.1016\/j.jtauto.2025.100313_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple sclerosis: mechanisms and immunotherapy","volume":"97","author":"Baecher-Allan","year":"2018","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib53","article-title":"A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis","volume":"255","author":"Weiner","year":"2008","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jtauto.2025.100313_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(14)70305-9","article-title":"Role of the innate and adaptive immune responses in the course of multiple sclerosis","volume":"14","author":"Hemmer","year":"2015","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2009.09.015","article-title":"Innate and adaptive autoimmunity directed to the central nervous system","volume":"64","author":"Bhat","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.jtauto.2025.100313_bib56","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1038\/346183a0","article-title":"T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis","volume":"346","author":"Ota","year":"1990","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jtauto.2025.100313_bib57","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.jtauto.2025.100313_bib58","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awh176","article-title":"Development of biomarkers in multiple sclerosis","volume":"127","author":"Bielekova","year":"2004","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.jtauto.2025.100313_bib59","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.jtauto.2025.100313_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.jtauto.2025.100313_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/eji.1830271211","article-title":"Myelin oligodendrocyte glycoprotein\u2010induced autoimmune encephalomyelitis is chronic\/relapsing in perforin knockout mice, but monophasic in fas\u2010 and fas ligand\u2010deficient lpr and gld mice","volume":"27","author":"Malipiero","year":"1997","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib62","doi-asserted-by":"crossref","DOI":"10.1172\/JCI132531","article-title":"Myelin-specific CD8 T cells exacerbate brain inflammation in CNS autoimmunity","volume":"130","author":"Wagner","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15632","article-title":"IL-17-producing \u03b3\u03b4 T cells switch migratory patterns between resting and activated states","volume":"8","author":"McKenzie","year":"2017","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.jtauto.2025.100313_bib64","doi-asserted-by":"crossref","DOI":"10.1172\/JCI200114235","article-title":"Mechanisms for the induction of autoimmunity by infectious agents","volume":"108","author":"Wucherpfennig","year":"2001","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100313_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/S0165-5728(00)00226-5","article-title":"Degeneracy in T-cell antigen recognition \u2013 implications for the pathogenesis of autoimmune diseases","volume":"107","author":"Hemmer","year":"2000","journal-title":"J. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.jtauto.2025.100313_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-021-00498-5","article-title":"B cells in multiple sclerosis \u2014 from targeted depletion to immune reconstitution therapies","volume":"17","author":"Cencioni","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.jtauto.2025.100313_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"Iwasaki","year":"2015","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.jtauto.2025.100313_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2021.09.014","article-title":"Microglia: immune and non-immune functions","volume":"54","author":"Borst","year":"2021","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.jtauto.2025.100313_bib69","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.177.6.4196","article-title":"Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response","volume":"177","author":"Karni","year":"2006","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100313_bib70","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1100789","article-title":"Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis","volume":"187","author":"Jiang","year":"2011","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/hdy.2010.54","article-title":"Epigenetics and gene expression","volume":"105","author":"Gibney","year":"2010","journal-title":"Heredity"},{"key":"10.1016\/j.jtauto.2025.100313_bib72","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.3390\/cells11213439","article-title":"The DNA methylation in neurological diseases","volume":"11","author":"Younesian","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib73","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-019-1667-1","article-title":"Aberrant DNA methylation profile exacerbates inflammation and neurodegeneration in multiple sclerosis patients","volume":"17","author":"Celarain","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jtauto.2025.100313_bib74","first-page":"17","article-title":"Frontiers | the interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis","author":"Angelini","year":"2023","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100313_bib75","first-page":"5","article-title":"Regulatory CD4+CD25high T cells, activated CD4+CD25highCD127high T cells and multiple sclerosis","author":"Pettr\u00e9","year":"2009","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.jtauto.2025.100313_bib76","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.3390\/ijms25168921","article-title":"A comprehensive examination of the role of epigenetic factors in multiple sclerosis","volume":"25","author":"Manna","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100313_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/ana.26959","article-title":"DNA methylation in the anti\u2010mullerian hormone gene and the risk of disease activity in multiple sclerosis","volume":"96","author":"Giordano","year":"2024","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.jtauto.2025.100313_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.51618","article-title":"Epigenetic control of ataxin\u20101 in multiple sclerosis","volume":"9","author":"Ma","year":"2022","journal-title":"Ann. Clin. Translat. Neurol."},{"key":"10.1016\/j.jtauto.2025.100313_bib79","article-title":"Epigenetic and mitochondrial metabolic dysfunction in multiple sclerosis: a review of herbal drug approaches and current clinical trials","volume":"2025\u201304\u201303","author":"Ashwani","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jtauto.2025.100313_bib80","article-title":"Histone deacetylases and their inhibitors in inflammatory diseases","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04732-5","article-title":"DNA methylation as a mediator of HLA-DRB1\u221715:01 and a protective variant in multiple sclerosis","volume":"9","author":"Kular","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.jtauto.2025.100313_bib82","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201800039","article-title":"Loss of HDAC11 ameliorates clinical symptoms in a multiple sclerosis mouse model","volume":"1","author":"Sun","year":"2018","journal-title":"Life Sci. Alliance"},{"issue":"3","key":"10.1016\/j.jtauto.2025.100313_bib83","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae182","article-title":"Propionic acid promotes neurite recovery in damaged multiple sclerosis neurons","volume":"6","author":"Gisevius","year":"2024","journal-title":"Brain Commun."},{"issue":"11","key":"10.1016\/j.jtauto.2025.100313_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(09)70262-5","article-title":"Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies","volume":"8","author":"Urdinguio","year":"2009","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-08623-5","article-title":"DNA methylation in demyelinated multiple sclerosis hippocampus","volume":"7","author":"Chomyk","year":"2017","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.jtauto.2025.100313_bib86","article-title":"Disease-modifying treatments and cognition in relapsing-remitting multiple sclerosis","volume":"94","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2025.100313_bib87","first-page":"11","article-title":"Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action","author":"Damal","year":"2013","journal-title":"Biol. Targets & Ther."},{"issue":"6","key":"10.1016\/j.jtauto.2025.100313_bib88","article-title":"Natalizumab treatment of relapsing remitting multiple sclerosis has no long-term effects on the proportion of circulating regulatory T cells","volume":"12","author":"Tanasescu","year":"2023","journal-title":"Neurol. Therap."},{"key":"10.1016\/j.jtauto.2025.100313_bib89","first-page":"14","article-title":"Immune reconstitution following alemtuzumab therapy is characterized by exhausted T cells, increased regulatory control of proinflammatory T cells and reduced B cell control - PubMed","author":"Mr","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jtauto.2025.100313_bib90","article-title":"An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis","volume":"24","author":"Dumitrescu","year":"2023","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.jtauto.2025.100313_bib91","doi-asserted-by":"crossref","DOI":"10.2147\/ITT.S513629","article-title":"Cell-based therapeutic strategies for autoimmune diseases","author":"Quero","year":"2025","journal-title":"Immuno. Target. Therap."},{"issue":"6295","key":"10.1016\/j.jtauto.2025.100313_bib92","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jtauto.2025.100313_bib93","article-title":"Current status of intratumour microbiome in cancer and engineered exogenous microbiota as a promising therapeutic strategy","author":"Chen","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100313_bib94","doi-asserted-by":"crossref","DOI":"10.1038\/s44222-023-00119-4","article-title":"Bacterial therapies at the interface of synthetic biology and nanomedicine","volume":"2","author":"Hahn","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"issue":"40","key":"10.1016\/j.jtauto.2025.100313_bib95","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1711235114","article-title":"Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models","volume":"114","author":"Cekanaviciute","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jtauto.2025.100313_bib96","doi-asserted-by":"crossref","DOI":"10.1080\/1040841X.2021.1902940","article-title":"Next-generation probiotics: a promising approach towards designing personalized medicine","author":"Singh","year":"2021","journal-title":"Crit. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib97","article-title":"Immunomodulatory mechanisms of lactobacilli","volume":"10","author":"Wells","year":"2011","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.jtauto.2025.100313_bib98","article-title":"Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes\u2013PubMed","volume":"6","author":"S","year":"2015","journal-title":"Front. Genet."},{"issue":"8","key":"10.1016\/j.jtauto.2025.100313_bib99","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1038\/s41579-018-0036-x","article-title":"Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier","volume":"16","author":"Martens","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"issue":"12","key":"10.1016\/j.jtauto.2025.100313_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10122382","article-title":"Akkermansia muciniphila and Faecalibacterium prausnitzii in immune-related diseases","volume":"10","author":"Effendi","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.jtauto.2025.100313_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115568","article-title":"Faecalibacterium prausnitzii, Bacteroides faecis and Roseburia intestinalis attenuate clinical symptoms of experimental colitis by regulating Treg\/Th17 cell balance and intestinal barrier integrity","author":"Mohebali","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jtauto.2025.100313_bib102","first-page":"11","article-title":"Frontiers | human commensal prevotella histicola Ameliorates disease as effectively as interferon-beta in the experimental autoimmune encephalomyelitis","author":"Shahi","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib103","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2143222","article-title":"A metabolically engineered bacterium controls autoimmunity and inflammation by remodeling the pro-inflammatory microenvironment","volume":"14","author":"Das","year":"2022","journal-title":"Gut Microbes"},{"issue":"2","key":"10.1016\/j.jtauto.2025.100313_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2008.06.034","article-title":"Association between Mycobacterium avium subsp. paratuberculosis DNA in blood and cellular and humoral immune response in inflammatory bowel disease patients and controls","volume":"13","author":"Juste","year":"2009","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib105","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2002.20.1.142","article-title":"Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma","volume":"20","author":"Toso","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.jtauto.2025.100313_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/sj.cgt.7700634","article-title":"Pilot trial of genetically modified, attenuated salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients","volume":"10","author":"Nemunaitis","year":"2003","journal-title":"Cancer Gene Ther."},{"issue":"6","key":"10.1016\/j.jtauto.2025.100313_bib107","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.01935-06","article-title":"Inhibitory effect of enterohepatic Helicobacter hepaticus on innate immune responses of mouse intestinal epithelial cells","volume":"75","author":"Sterzenbach","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jtauto.2025.100313_bib108","article-title":"Oral administration of Lactococcus lactis expressing synthetic genes of myelin antigens in decreasing experimental autoimmune encephalomyelitis in rats","author":"Kasarello","year":"2015","journal-title":"Med. Sci. Monit.: Int. Med. J. Experiment. Clin. Res."},{"key":"10.1016\/j.jtauto.2025.100313_bib109","article-title":"Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies","author":"Chen","year":"2023","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib110","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-022-01364-2","article-title":"Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis","volume":"10","author":"Bianchimano","year":"2022","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib111","article-title":"Cancer immunotherapy using Listeria monocytogenes and listerial virulence factors","volume":"42","author":"Wood","year":"2008","journal-title":"Immunol. Res."},{"issue":"1_supplement_1","key":"10.1016\/j.jtauto.2025.100313_bib112","article-title":"Interferon-\u03b2 mechanisms of action in multiple sclerosis","volume":"74","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jtauto.2025.100313_bib113","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-012-0163-4","article-title":"Interferon beta and glatiramer acetate therapy","volume":"10","author":"McGraw","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jtauto.2025.100313_bib114","series-title":"A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis","author":"Polman","year":"2006"},{"issue":"19","key":"10.1016\/j.jtauto.2025.100313_bib115","article-title":"Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis","volume":"93","year":"2019","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jtauto.2025.100313_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases","volume":"9","author":"Clifford","year":"2010","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.jtauto.2025.100313_bib117","doi-asserted-by":"crossref","DOI":"10.1038\/nrn2480","article-title":"Remyelination in the CNS: from biology to therapy","volume":"9","author":"Franklin","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.jtauto.2025.100313_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.tins.2016.02.004","article-title":"Pushing forward: remyelination as the new frontier in CNS diseases","volume":"39","author":"Kremer","year":"2016","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100313_bib119","doi-asserted-by":"crossref","DOI":"10.1080\/08916930601183522","article-title":"The blood\u2013brain-barrier in multiple sclerosis: functional roles and therapeutic targeting","volume":"40","author":"Correale","year":"2007","journal-title":"Autoimmunity"},{"issue":"5","key":"10.1016\/j.jtauto.2025.100313_bib120","article-title":"New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis","volume":"29","author":"Villoslada","year":"2020","journal-title":"Expet Opin. Invest. Drugs"}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909025000486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909025000486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:27:15Z","timestamp":1772915235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909025000486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":120,"alternative-id":["S2589909025000486"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2025.100313","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redefining multiple sclerosis therapy through microbial immunomodulation and epigenetic control","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2025.100313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100313"}}